Klinik für Frauenheilkunde - Academic Profile

Publications

Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer

Martine Piccart , Marion Procter , Brian Leyland‐Jones +29 more

One year of treatment with trastuzumab after adjuvant chemotherapy significantly improves disease-free survival among women with HER2-positive breast cancer. (ClinicalTrials.gov...

2005 New England Journal of Medicine 5034 citations

2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial

Ian Smith , Marion Procter , Richard D. Gelber +21 more

2007 The Lancet 1503 citations

Institution Info

Type: healthcare
Country: DE
Publications: 2
Citations: 6,537

External Links

Identifiers

ROR: https://ror.org/00a0bqh48